Sutthatip.b Line Sutthatip.b Line
2020 has adversely direct impacted the Group’s operations due to mandatory closure decree in late March, resulting in the first quarter revenue of THB 227.64 million, reducing by THB 48.79 million or 18
the Republic of Indonesia, with the production capacity of 275 megawatts and 20-year Power Purchase Agreement. The Commercial Operation Date is expected to be within the year 2021. 1.1.4 MRT Pink Line
addition, the economic slowdown in 2019 created a price war competition in this industry. For this quarter, the outbreak of COVID-19 since middle of March 2020 caused a direct impact toward customers
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a
direct sales market and alter its marketing budget in line with revenues from sales and focused more on online channels. The company has the distribution costs for the first six month in total of 229.1
last year. - Controlling in selling cost per revenue and maintaining at 14%, increase in selling cost mainly are from direct cost eg. Transportation cost. - Increase in administrative expense of 11
Branch.Rangsit since March 22, 2020. However, the Group can provide services through online ordering channel (E-Commerce) and direct phone ordering to our sales team and sales representative as usual. By the way
; (4) advertising through media which is conformed to the rules as prescribed in Clause 10. 3 Clause 6 The direct distribution of information to investors shall be made in any of the following means: (1